Produkty 338976-76-4

CAS 338976-76-4 występuje w naszej ofercie pod nazwami: 3Alpha,7Alpha-Dihydroxycoprostanic Acid-d3, >95% (HPLC), 3α,7α–Dihydroxycoprostanic acid–d3, 3α,7α-Dihydroxycoprostanic acid-d3, 99.0%. Oferty producentów: TRC, GLPBio, MedChemExpress. Dostępne opakowania: 0,5mg, 2,5mg, 5mg, 500μg, 500 μg.

3Alpha,7Alpha-Dihydroxycoprostanic Acid-d3, >95% (HPLC)
TRC
  • opakowanie: 0,5mg, 2,5mg, 5mg
  • Warianty: 3
Zobacz produkt
3α,7α–Dihydroxycoprostanic acid–d3
GLPBio
  • opakowanie: 500μg
  • Warianty: 1
od 2773,47
Zobacz produkt
3α,7α-Dihydroxycoprostanic acid-d3, 99.0%
MedChemExpress
  • opakowanie: 500 μg
  • Warianty: 1
od 2808,88
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(6R)-6-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-(trideuteriomethyl)heptanoic acid (CAS 338976-76-4) to związek chemiczny o wzorze sumarycznym C27H46O4 i masie molowej 437.7 g/mol. Nazwa systematyczna IUPAC: (6R)-6-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-(trideuteriomethyl)heptanoic acid. InChIKey: ITZYGDKGRKKBSN-WNOXKDKUSA-N.

Dane identyfikacyjne
Wzór sumarycznyC27H46O4
Masa molowa437.7 g/mol
Nazwa IUPAC(6R)-6-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-(trideuteriomethyl)heptanoic acid
InChIKeyITZYGDKGRKKBSN-WNOXKDKUSA-N
SMILES[2H]C([2H])([2H])C(CCC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C)C(=O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 3Alpha,7Alpha-Dihydroxycoprostanic Acid-d3, 3|A,7|A-Dihydroxycoprostanic acid-d3, 3a,7a-Dihydroxycoprostanic Acid-d3, 3alpha,7alpha-DihydroxycoprostanicAcid-d3
Powiązane formy tego związku
(2R,6R)-6-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid C27H46O4
(6R)-6-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid C27H46O4
(2S,6R)-6-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid C27H46O4
Izomery (ten sam wzór sumaryczny)
trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,5R)-5-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol;hydrate C27H46O4
methyl (4R)-4-[(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate C27H46O4
(3S,5S,8S,9S,10R,13S,14S,17R)-17-[(2S,3R,4R)-3,4-dihydroxy-6-methylheptan-2-yl]-3-hydroxy-10,13-dimethyl-1,2,3,4,5,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-6-one C27H46O4